Dutasteride in the treatment of benign prostatic hyperplasia: an update / 中华男科学杂志
National Journal of Andrology
;
(12): 63-67, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-266209
ABSTRACT
Benign prostatic hyperplasia (BPH) is a common disease in older men. At present, 5alpha reductase inhibitor-based medication, preferred by most BPH patients as the first-choice therapy, is taking place of traditional transurethral resection of the prostate. This article presents an update of the researches on the treatment of BPH with dutasteride--a novel 5 alpha-reductase inhibitor.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Hiperplasia Prostática
/
Azaesteroides
/
Usos Terapéuticos
/
Quimioterapia
/
Inhibidores de 5-alfa-Reductasa
/
Dutasterida
Límite:
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS